Anti-CD42d antibody (17-477 aa) (STJ11107110)

SKU:
STJ11107110

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.09% Sodium Azide, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:1000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: GP5
Gene ID: 2814
Uniprot ID: GPV_HUMAN
Immunogen Region: 17-477 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 17-477 of human CD42d (NP_004479.1).
Immunogen Sequence: QPFPCPPACKCVFRDAAQCS GGDVARISALGLPTNLTHIL LFGMGRGVLQSQSFSGMTVL QRLMISDSHISAVAPGTFSD LIKLKTLRLSRNKITHLPGA LLDKMVLLEQLFLDHNALRG IDQNMFQKLVNLQELALNQN QLDFLPASLFTNLENLKLLD LSGNNLTHLPKGLLGAQAKL ERLLLHSNRLVSLDSGLLNS LGALTELQFHRNHIRSIAPG AFDRLPNLSSLTLSRNHLA
Tissue Specificity Platelets and megakaryocytes.
Post Translational Modifications The N-terminus is blocked.
Function The GPIb-V-IX complex functions as the vWF receptor and mediates vWF-dependent platelet adhesion to blood vessels. The adhesion of platelets to injured vascular surfaces in the arterial circulation is a critical initiating event in hemostasis.
Protein Name Platelet Glycoprotein V
Gpv
Glycoprotein 5
Cd Antigen Cd42d
Database Links Reactome: R-HSA-140837
Reactome: R-HSA-430116
Reactome: R-HSA-75892
Reactome: R-HSA-76009
Reactome: R-HSA-9673221
Reactome: R-HSA-9845620
Reactome: R-HSA-9846298
Cellular Localisation Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Names Anti-Platelet Glycoprotein V antibody
Anti-Gpv antibody
Anti-Glycoprotein 5 antibody
Anti-Cd Antigen Cd42d antibody
Anti-GP5 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance